The effectiveness and safety of non-pharmacological intervention for pain management in Parkinson's disease: A systematic review

Authors: Huissoud, M., Boussac, M., Joineau, K., Harroch, E., Brefel-Courbon, C., Descamps, E.

Source: In Revue Neurologique October 2024 180(8):715-735

French guidelines for the diagnosis and management of Tourette syndrome

Authors: Hartmann, A., Ansquer, S., Brefel-Courbon, C., Burbaud, P., Castrioto, A., Czernecki, V., Damier, P., Deniau, E., Drapier, S., Jalenques, I., Marechal, O., Priou, T., Spodenkiewicz, M., Thobois, S., Roubertie, A., Witjas, T., Anheim, M.

Source: In Revue Neurologique October 2024 180(8):818-827

Impact of therapeutic education on the evolution of social representations of medication in patients with Parkinson's disease: A quantitative and qualitative study (ETPARK REMED)

Authors: Faurie, I., Harroch, E., Scotto d’Apollonia, C., Corte, S., Arcari, C., Mohara, C., Barthelemy, C., Fabre, M.H., Boussac, M., Damase-Michel, C., Almudever, B., Croity-Belz, S., Brefel-Courbon, C.

Source: In Revue Neurologique December 2023 179(10):1086-1094

Validation of a non-motor fluctuations questionnaire in Parkinson's disease

Authors: Faggianelli, F., Jr., Loundou, A., Baumstarck, K., Nathalie, S., Auquier, P., Eusebio, A., Defebvre, L., Brefel-Courbon, C., Houeto, J.-L., Maltete, D., Tranchant, C., Derkinderen, P., Geny, C., Krystkowiak, P., Jean-Philippe, B., Macia, F., Durif, F., Poujois, A., Borg, M., Azulay, J.-P., Witjas, T.

Source: In Revue Neurologique April 2022 178(4):347-354

Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation

Authors: Fernández-Rodríguez, B., Dupouy, J., Harroch, E., Fabre-Delcros, M.-H., Barthélémy, C., Loubière, P., Barange, K., Brefel-Courbon, C., Rascol, O., Ory-Magne, F. ^*

Source: In Revue Neurologique October 2021 177(8):919-923

Chronic pain in Parkinson's disease: Clinical and pathophysiological aspects

Authors: Marques, A. ^*, Brefel-Courbon, C.

Source: In Revue Neurologique April 2021 177(4):394-399

Abnormal pain perception in patients with Multiple System Atrophy

Authors: Ory-Magne, F., Pellaprat, J., Harroch, E., Galitzsky, M., Rousseau, V., Pavy-Le Traon, A., Rascol, O., Gerdelat, A., Brefel-Courbon, C.

Source: In Parkinsonism and Related Disorders March 2018 48:28-33

Dopa-sensibilité et Dopa-résistance : autant de réponses que de symptômes

Alternate Title: Dopa-responsive and Dopa-resistant symptoms: Many symptoms, many responses (English)

Authors: Brefel-Courbon, C.

Source: In Pratique Neurologique - FMC March 2017 8(2):66-69

A longitudinal follow-up study of the quantification of dopamine transporters with 123I-Ioflupane (DaTscan)

Alternate Title: Suivi longitudinal de la quantification des transporteurs de la dopamine avec l’123I-Ioflupane (DaTscan) (French)

Authors: Fayolle, H., Gantet, P., Salabert, A.S., Delrieu, J., Brefel-Courbon, C., Ory-Magne, F., Voisin, T., Payoux, P.

Source: In Medecine Nucleaire February 2017 41(1):36-41

Trial of Lixisenatide in Early Parkinson's Disease.

Authors: Meissner, W. G., Remy, P., Giordana, C., Maltête, D., Derkinderen, P., Houéto, J.-L., Anheim, M., Benatru, I., Boraud, T., Brefel-Courbon, C., Carrière, N., Catala, H., Colin, O., Corvol, J.-C., Damier, P., Dellapina, E., Devos, D., Drapier, S., Fabbri, M., Ferrier, V.

Source: New England Journal of Medicine; 4/4/2024, Vol. 390 Issue 13, p1176-1185, 10p

An individual rehabilitation program: Evaluation by Parkinsonian patients and their physiotherapists

Alternate Title: Évaluation d’un programme de rééducation personnalisé dans la maladie de Parkinson par des patients et leurs kinésithérapeutes (French)

Authors: Ory Magne, F., Fabre, N., Gu, C., Pastorelli, C., Tardez, S., Marchat, J.-C., Marque, P., Brefel Courbon, C.

Source: In Revue Neurologique November 2014 170(11):680-684

Éducation thérapeutique chez le patient parkinsonien : le programme ETPARK

Alternate Title: A therapeutic educational program in Parkinson's disease: ETPARK (English)

Authors: Ory Magne, F., Arcari, C., Canivet, C., Sarrail, M., Fabre, M.H., Mohara, C., Brefel Courbon, C.

Source: In Revue Neurologique February 2014 170(2):128-133

L’éducation thérapeutique du patient

Alternate Title: Educational program of the patient (English)

Authors: Arcari, C., Canivet, C., Mohara, C., Ory-Magne, F., Brefel-Courbon, C.

Source: In Pratique Neurologique - FMC February 2012 3(1):55-61

Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson’s disease

Authors: Marchand-Pauvert, V., Gerdelat-Mas, A., Ory-Magne, F., Calvas, F., Mazevet, D., Meunier, S., Brefel-Courbon, C., Vidailhet, M., Simonetta-Moreau, M.

Source: In Clinical Neurophysiology 2011 122(5):1019-1026

La lévodopa modifie les seuils nociceptifs chez le patient parkinsonien

Alternate Title: Levodopa modifies pain thresholds in Parkinson's disease patients (English)

Authors: Slaoui, T., Mas-Gerdelat, A., Ory-Magne, F., Rascol, O., Brefel-Courbon, C.

Source: In Revue Neurologique 2007 163(1):66-71

Drug-induced myoclonus: a French pharmacovigilance database study

Alternate Title: Myoclonies induites par les médicaments : une enquête française de pharmacovigilance (French)

Authors: Brefel-Courbon, C., Gardette, V., Ory, F., Montastruc, J.L.

Source: In Neurophysiologie Clinique / Clinical Neurophysiology 2006 36(5):333-336

The management of patients with early Parkinson's disease

Authors: Rascol, O. ^∗, Payoux, P., Ferreira, J., Brefel-Courbon, C.

Source: In Parkinsonism and Related Disorders 2002 9(1):61-67

Stratégies pharmacothérapeutiques actuelles et futures dans la prise en charge de la maladie de Parkinson.

Authors: Brefel-Courbon, C.¹, Rascol, O.¹

Source: Disease Management & Health Outcomes. Jun2001 Special Issue 1, Vol. 9 Issue 6, p31-39. 9p.

Subject Terms: *DOPAMINE agonists, *PARKINSON'S disease treatment, *DOPA, *THERAPEUTICS

Prévalence des troubles compulsifs chez des patients traités par agonistes dopaminergiques pour un adénome hypophysaire

Authors: Duval, M., Bongard, V., Brusq, C., Vialon, M., Arbus, C., Brefel-Courbon, C., Geslot, A., Mouly, C., Caron, P., Bennet, A., Grunenwald, S., Vezzosi, D.

Source: In Annales d'Endocrinologie September 2020 81(4):148-148

This result is not displayed to guests.
Login for full access.